Drug interactions
Sipuleucel-t + Vinorelbine
Severity: Moderate
Sipuleucel-t and Vinorelbine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sipuleucel-T is an autologous cellular immunotherapy that relies on a functioning immune response. Cytotoxic chemotherapy such as vinorelbine causes myelosuppression and immunosuppression, which may blunt the immune activation the product is meant to produce.
What this interaction means in plain words
Sipuleucel-t and Vinorelbine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Pharmacodynamic antagonism: chemotherapy-induced immunosuppression may reduce the immune response to sipuleucel-T.
What to do
Avoid giving vinorelbine around leukapheresis and infusion where possible, and consider the timing of chemotherapy relative to the sipuleucel-T course with the oncology team. Monitor clinical response.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Sipuleucel-t and Vinorelbine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Vinorelbine
Frequently asked questions
Can I take Sipuleucel-t with Vinorelbine?
MediHelp rates the interaction as moderate. Sipuleucel-t and Vinorelbine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sipuleucel-T is an autologous cellular immunotherapy that relies on a functioning immune response. Cytotoxic chemotherapy such as vinorelbine causes myelosuppression and immunosuppression, which may blunt the immune activation the product is meant to produce.
How serious is the interaction between Sipuleucel-t and Vinorelbine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid giving vinorelbine around leukapheresis and infusion where possible, and consider the timing of chemotherapy relative to the sipuleucel-T course with the oncology team. Monitor clinical response.
What other medicines interact with Vinorelbine?
MediHelp also lists interactions of Vinorelbine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Belatacept. The full list is on the Vinorelbine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
